Detalhe da pesquisa
1.
Ibrutinib as part of risk-stratified treatment for post-transplant lymphoproliferative disorder: The phase 2 TIDaL trial.
Blood
; 2024 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38643491
2.
Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I-Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE Trial.
Circulation
; 148(21): 1680-1690, 2023 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37746692
3.
Genetic and genomic analysis of acute lymphoblastic leukemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ clinical trials.
Haematologica
; 107(9): 2051-2063, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34788984
4.
Outcomes of older patients with primary central nervous system lymphoma treated in routine clinical practice in the UK: methotrexate dose intensity correlates with response and survival.
Br J Haematol
; 190(3): 394-404, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32232989
5.
Management of adults with T-cell lymphoblastic leukemia.
Blood
; 129(9): 1134-1142, 2017 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28115371
6.
Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial.
Lancet Oncol
; 19(10): 1328-1337, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30220622
7.
Relapse in teenage and young adult patients treated on a paediatric minimal residual disease stratified ALL treatment protocol is associated with a poor outcome: results from UKALL2003.
Br J Haematol
; 181(4): 515-522, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29687881
8.
Efficacy and toxicity of a paediatric protocol in teenagers and young adults with Philadelphia chromosome negative acute lymphoblastic leukaemia: results from UKALL 2003.
Br J Haematol
; 172(3): 439-51, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26683485
9.
Results of a multicentre UK-wide retrospective study evaluating the efficacy of pixantrone in relapsed, refractory diffuse large B cell lymphoma.
Br J Haematol
; 173(6): 896-904, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26956150
10.
Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial.
Lancet Oncol
; 15(8): 809-18, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24924991
11.
Early morphological response is significantly associated with, but does not accurately predict, relapse in teenagers and young adults aged 10-24 years with acute lymphoblastic leukaemia (ALL): results from UKALL2003.
Br J Haematol
; 184(4): 663-666, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29468646
12.
Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003.
Br J Haematol
; 166(3): 421-4, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24708207
13.
Outcome of Down syndrome associated acute lymphoblastic leukaemia treated on a contemporary protocol.
Br J Haematol
; 165(4): 552-5, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24428704
14.
Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial.
Lancet Oncol
; 14(3): 199-209, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23395119
15.
Resolution of persistent SARS-CoV-2 infection with prolonged intravenous remdesivir and vaccination in a patient post CAR-T.
Int J Hematol
; 117(5): 765-768, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36757522
16.
Time to Cure for Childhood and Young Adult Acute Lymphoblastic Leukemia Is Independent of Early Risk Factors: Long-Term Follow-Up of the UKALL2003 Trial.
J Clin Oncol
; 40(36): 4228-4239, 2022 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35714315
17.
Rationale and Design of the Cardiac CARE Trial: A Randomized Trial of Troponin-Guided Neurohormonal Blockade for the Prevention of Anthracycline Cardiotoxicity.
Circ Heart Fail
; 15(7): e009445, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35766037
18.
In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial.
Lancet Haematol
; 9(4): e276-e288, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35358442
19.
Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study.
Leukemia
; 36(3): 625-636, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34657128
20.
Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial.
Lancet Haematol
; 9(4): e262-e275, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35358441